|
Post by sla55 on Jan 4, 2019 13:59:24 GMT -5
|
|
|
Post by ilovekauai on Jan 4, 2019 14:04:14 GMT -5
Okay, so what does this mean?
|
|
|
Post by traderdennis on Jan 4, 2019 14:11:29 GMT -5
It looks like Sabby participated in the latest offering and in my opinion, covered their short from September (hedged by 2.38 warrants) and now is long. I would expect them to short again if the price goes above 1.75 in the next 12 months.
|
|
|
Post by ilovekauai on Jan 4, 2019 14:13:19 GMT -5
Thank you TD
|
|
|
Post by peppy on Jan 4, 2019 14:13:45 GMT -5
|
|
|
Post by mytakeonit on Jan 4, 2019 15:34:37 GMT -5
If Sabby shorts as the train is leaving the station ... good luck with that.
|
|
|
Post by traderdennis on Jan 4, 2019 18:07:49 GMT -5
If Sabby shorts as the train is leaving the station ... good luck with that. Thats what you said the last time sabby shorted at $2.75
|
|
|
Post by patten1962 on Jan 4, 2019 18:18:37 GMT -5
It looks like Sabby participated in the latest offering and in my opinion, covered their short from September (hedged by 2.38 warrants) and now is long. I would expect them to short again if the price goes above 1.75 in the next 12 months. What will it take to break $1.70?
|
|
|
Post by sportsrancho on Jan 4, 2019 18:36:11 GMT -5
It looks like Sabby participated in the latest offering and in my opinion, covered their short from September (hedged by 2.38 warrants) and now is long. I would expect them to short again if the price goes above 1.75 in the next 12 months. What will it take to break $1.70? A partner or a buy-in.
|
|
|
Post by sayhey24 on Jan 4, 2019 18:46:03 GMT -5
If Sabby shorts as the train is leaving the station ... good luck with that. Thats what you said the last time sabby shorted at $2.75 I have been hanging around MNKD for awhile, probably longer than many on this board.
At this point not much surprises me but today's call did. I fully expected Mike to announce a special vote to approve another 150+k authorized shares. Instead he doubled down on the plan from last spring plus the addition of the migraine development and the announcement that MNKD is now funded through mid-2020.
This would seem not good news to those holding short and I would expect an orderly exit by most. What happens in 12 months is any ones guess. If Mike continues to delivery on the plan, afrezza sales continue to increase, Dr. Kendall makes inroads on changes to the SOC, maybe an international partner, may RLS comes out of the closet, etc. Sabby may not even consider shorting at what may be a bargain basement price less than $2.
With that said MNKD is clearly a take-over target for any company who wants to potentially get into the diabetes space in a big way if what VDex is saying in their white paper is correct. One of my take-aways from their paper is they verified what Al Mann was seeing in his studies years ago. I think if Dr. Kendall has had the chance to read it, it will be his impression too. Without the shares on the shelf I sure hope Mike has a plan, just in case.
|
|
|
Post by Clement on Jan 4, 2019 18:50:34 GMT -5
8 weeks from Jan 14
|
|
|
Post by golfeveryday on Jan 4, 2019 19:01:19 GMT -5
What will it take to break $1.70? A partner or a buy-in. i think they are now going alone Afrezza (at least for 2019) with a TS diversification strategy and possible buy in for whole company or buy out at some point.
|
|
|
Post by centralcoastinvestor on Jan 4, 2019 19:19:45 GMT -5
Thats what you said the last time sabby shorted at $2.75 I have been hanging around MNKD for awhile, probably longer than many on this board.
At this point not much surprises me but today's call did. I fully expected Mike to announce a special vote to approve another 150+k authorized shares. Instead he doubled down on the plan from last spring plus the addition of the migraine development and the announcement that MNKD is now funded through mid-2020.
This would seem not good news to those holding short and I would expect an orderly exit by most. What happens in 12 months is any ones guess. If Mike continues to delivery on the plan, afrezza sales continue to increase, Dr. Kendall makes inroads on changes to the SOC, maybe an international partner, may RLS comes out of the closet, etc. Sabby may not even consider shorting at what may be a bargain basement price less than $2.
With that said MNKD is clearly a take-over target for any company who wants to potentially get into the diabetes space in a big way if what VDex is saying in their white paper is correct. One of my take-aways from their paper is they verified what Al Mann was seeing in his studies years ago. I think if Dr. Kendall has had the chance to read it, it will be his impression too. Without the shares on the shelf I sure hope Mike has a plan, just in case.
I bought my first shares in 2007. What a genius. How could I lose with such an amazing product, right?
|
|
|
Post by mytakeonit on Jan 4, 2019 20:16:43 GMT -5
If Sabby shorts as the train is leaving the station ... good luck with that. Thats what you said the last time sabby shorted at $2.75 Well obviously it was my giving them Good Luck that helped them.
|
|
|
Post by mytakeonit on Jan 4, 2019 20:19:34 GMT -5
It looks like Sabby participated in the latest offering and in my opinion, covered their short from September (hedged by 2.38 warrants) and now is long. I would expect them to short again if the price goes above 1.75 in the next 12 months. What will it take to break $1.70? $1.71
|
|